Details for New Drug Application (NDA): 076856
✉ Email this page to a colleague
The generic ingredient in DANTROLENE SODIUM is dantrolene sodium. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dantrolene sodium profile page.
Summary for 076856
Tradename: | DANTROLENE SODIUM |
Applicant: | Impax Labs |
Ingredient: | dantrolene sodium |
Patents: | 0 |
Pharmacology for NDA: 076856
Physiological Effect | Decreased Striated Muscle Contraction Decreased Striated Muscle Tone |
Medical Subject Heading (MeSH) Categories for 076856
Suppliers and Packaging for NDA: 076856
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DANTROLENE SODIUM | dantrolene sodium | CAPSULE;ORAL | 076856 | ANDA | Amneal Pharmaceuticals of New York LLC | 0115-4411 | 0115-4411-01 | 100 CAPSULE in 1 BOTTLE (0115-4411-01) |
DANTROLENE SODIUM | dantrolene sodium | CAPSULE;ORAL | 076856 | ANDA | Amneal Pharmaceuticals of New York LLC | 0115-4411 | 0115-4411-02 | 500 CAPSULE in 1 BOTTLE (0115-4411-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
Approval Date: | Mar 1, 2005 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Mar 1, 2005 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Mar 1, 2005 | TE: | AB | RLD: | No |
Complete Access Available with Subscription